OUR PORTFOLIO
The current portfolio comprises 13 companies: NeuroAdjuvants, Sera Prognostics, ContraDyn, MedCatheters, Q Therapeutics, Elute, XableCath, MedAnalytics, JST Research, Veritract, Complexa, PhotoPharmics and Catheter Connections.
Current Investments
Past Investments
Decipher GenX, Inc.
Numira, Inc.
G6, Inc.